HealthQuartzabout 2 hours ago
Nvidia-Backed Iambic Raises $150 Million
2 min read
Nvidia-backed AI drug developer Iambic raises $150 million in a U.S. IPO expected to close Friday on Nasdaq. The $16 share price sits between $15 and $17 boundaries. Iambic plans to use proceeds for three early-stage cancer drug candidates. Since 2019, the company drew $461.8 million in total investment.
Level
Hype check
Tap to vote and see what everyone thinks.
In this storyNvidia
